Month: June 2010

HPT/Axis, Inc. Awarded “Most Promising Life Science Technology Company” at 2010 Rice Alliance Life Science Venture Forum

This company is seeking to get approval of a drug protocol that will speed up the normalization of the Hypothalamus-Pituitary-Gonadal  (HPG) Axis after long term use of anabolic steroids or testosterone for medical or non medical uses.  Cessation of anabolics or testosterone replacement causes androgen -induced hypogonadism that can negatively impact someone’s health if the …

HPT/Axis, Inc. Awarded “Most Promising Life Science Technology Company” at 2010 Rice Alliance Life Science Venture Forum Read More »

Pipeline Problems by David Evans In the past month, two companies shelved their once-promising experimental HIV drugs, citing the challenging nature of bringing a profitable product to market. Has the overwhelming success of modern-day HIV drugs jeopardized the future of new HIV treatment options? Since Matt Sharp first learned that he was HIV positive in …

Read More »

AIDS activists ask AVEXA not to leave patients behind

June 17, 2010 Dr. Susan Cox Former Senior Vice President, Drug Development at Avexa Cc: Nathan Drona, Chairman of the Board at Avexa      Stephen Kerr, Board Secretary We, the undersigned, are asking the decision makers at Avexa to reconsider the decision to stop the development of apricitabine, a nucleoside analog that has shown good efficacy in …

AIDS activists ask AVEXA not to leave patients behind Read More »

HIV Salvage Patients Are Concerned About Recent Pharma Decisions

I am scared that companies are dropping new HIV medications Jun 17, 2010 Nelson, I emailed you before and you told me there were a few medications in research for people with resistance to all meds. But I just heard that two companies abandoned their research. What does that mean for someone like me who …

HIV Salvage Patients Are Concerned About Recent Pharma Decisions Read More »

AIDS Activists Support the Approval of Egrifta- But Some Conditions for Theratecnologies and Serono

17 May 2010 Paul Tran, BS Pharrn, RPh Advisors and Consultants Staff Center for Drug Evaluation and Research Food and Drug Administration 5630 Fishers Lane, HFD-21 Rockville, MD 20857 Dear Mr. Tran: On behalf ofthe Drug Development Committee (DDC) ofthe AIDS Treatment Activists Coalition (ATAC), I am writing to urge members ofthe Endocrinologic and Metabolic …

AIDS Activists Support the Approval of Egrifta- But Some Conditions for Theratecnologies and Serono Read More »

AIDS Activists Support the Approval of Egrifta- But With Some Conditions for Theratecnologies and Serono

17 May 2010 Paul Tran, BS Pharrn, RPh Advisors and Consultants Staff Center for Drug Evaluation and Research Food and Drug Administration 5630 Fishers Lane, HFD-21 Rockville, MD 20857 Dear Mr. Tran: On behalf ofthe Drug Development Committee (DDC) ofthe AIDS Treatment Activists Coalition (ATAC), I am writing to urge members ofthe Endocrinologic and Metabolic …

AIDS Activists Support the Approval of Egrifta- But With Some Conditions for Theratecnologies and Serono Read More »

Scroll to Top